Avecho Biotechnology Archives | Page 3 of 4 | Cannabiz

Avecho completes development of fast-onset CBD gummy product

by Martin Lane June 14, 2023April 30, 2024

Avecho Biotechnology has completed development of its first-generation proprietary Tocopheryl Phosphate Mixture (TPM) gummies containing CBD. […]

Avecho plots A$11m capital raise to underpin CBD clinical trial

by Steve Jones April 3, 2023April 30, 2024

Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI

by Martin Lane and Steve Jones November 1, 2022April 29, 2024

Modern medicine: can the dominance of oil and flower be challenged?

by Steve Jones October 6, 2022April 29, 2024

Avecho ‘adamant’ that S3 insomnia trial must be accepted overseas

by Steve Jones May 4, 2022April 29, 2024

Avecho’s topical CBD gel shows promise in treating osteoarthritis

by Martin Lane March 29, 2022April 29, 2024

Company news: Cann Global; Incannex; Creso Pharma; Rua Bioscience; Avecho; InhaleRx; Greenfern Industries; MGC Pharma

by cannabiz team March 3, 2022April 29, 2024

Avecho inks licence and supply deal for US recreational market

by Martin Lane February 2, 2022April 29, 2024

Avecho eyes arthritis market with Medterra tie up in the US

by Martin Lane December 20, 2021April 29, 2024

Australian Rheumatology Association calls for more evidence on cannabis

by Hannah Adler December 15, 2021April 29, 2024